Customized research for AIMT vs. AERI!

All in one page research, scroll down. Compare two other stocks.

Note: Don't forget to explore SpeculatingStocks further... from the SpeculatingStocks.com Homepage you can Discover Stocks, Post Anonymously, and React. No Login Required.

Done! Side by Side Research Below for AIMT vs. AERI.


↗ Join Our Free Email Newsletter.




Aimmune Therapeutics, Inc. vs. Aerie Pharmaceuticals, Inc.

Industry Match! Industry of Both AIMT and AERI:

Health Care/Life Sciences

AIMT
Data Last Updated: 2 days ago

↻  Update Column 1 to Most Recent

Key Statistics

Cap: 1.146B


P/E: N/A

P/S: N/A

Q P/B: 4.47

Y Rev: -

Q Rev: -

Beta: 0.53

AIMT Share Stats

Outstanding Shares

62.49M

Float Shares

34.21M

Percent of Float Short

29.69%

AIMT Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

AIMT Social Stats

Followers

0

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

AIMT in Pulse Portal

Stream of Posts

AIMT Symbol Page

Share AIMT Insights

Express Sentiment

'Buy' or 'Sell' AIMT

AIMT Profile

CEO

Dr. Jayson Donald Alexander Dallas

Exchange

Nasdaq

Employees

215.00

About

Aimmune Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of desensitization treatments for peanut and other food allergies. Its portfolio includes the characterized oral desensitization immunotherapy system....

AIMT Financials

Annual Financials

Income Statement

Revenue

-

Net Income

(210.75M)

Cash Flow Statement

Change in Cash / Investments

34.02M

Balance Sheet

Cash / Investments

303.93M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

312.62M

Total Current Liabilities

38.01M

Total Assets

339.56M

Total Liabilities

40.61M

Stockholder Equity

298.95M

Quarterly Financials

Income Statement

Q Revenue

-

Q Net Income

(54.27M)

Cash Flow Statement

Q Change in Cash / Investments

(26.45M)

Balance Sheet

Q Cash / Investments

283.17M

Q Short Term Debt

1.97M

Q Long Term Debt

37.27M

Q Total Current Assets

291.39M

Q Total Current Liabilities

38.09M

Q Total Assets

344.15M

Q Total Liabilities

87.85M

Q Stockholder Equity

256.3M

AIMT Charts

10-Year Chart

AIMT 10-Year Chart

5-Year Chart

AIMT 5-Year Chart

1-Year Chart

AIMT 1-Year Chart

6-Month Chart

AIMT 6-Month Chart

3-Month Chart

AIMT 3-Month Chart

1-Month Chart

AIMT 1-Month Chart

1-Day Chart

AIMT 1-Day Chart

AERI
Data Last Updated: 5 days ago

↻  Update Column 2 to Most Recent

Key Statistics

Cap: 1.103B


P/E: N/A

P/S: 45.62

Q P/B: 5.74

Y Rev: 24.18M

Q Rev: 10.85M

Beta: 0.53

AERI Share Stats

Outstanding Shares

45.92M

Float Shares

40.44M

Percent of Float Short

13.40%

AERI Insider Stats

Percent Outstanding Insider Ownership

N/A

Percent Outstanding Institution Ownership

N/A

AERI Social Stats

Followers

1

B/S Rating Today

0

B/S Rating All-Time

N/A

More Social Data

AERI in Pulse Portal

Stream of Posts

AERI Symbol Page

Share AERI Insights

Express Sentiment

'Buy' or 'Sell' AERI

AERI Profile

CEO

Dr. Vicente J. Anido

Exchange

Nasdaq

Employees

353.00

About

Aerie Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of therapies for the treatment of patients with open-angle glaucoma, retinal diseases and other diseases of the eye. Its products include Rhopressa, Roclatan, AR-13503, and AR-1105....

AERI Financials

Annual Financials

Income Statement

Revenue

24.18M

Net Income

(232.57M)

Cash Flow Statement

Change in Cash / Investments

5.25M

Balance Sheet

Cash / Investments

202.82M

Short Term Debt

None

Long Term Debt

None

Total Current Assets

220.18M

Total Current Liabilities

50.78M

Total Assets

285.04M

Total Liabilities

57.24M

Stockholder Equity

227.81M

Quarterly Financials

Income Statement

Q Revenue

10.85M

Q Net Income

(47.95M)

Cash Flow Statement

Q Change in Cash / Investments

(53.95M)

Balance Sheet

Q Cash / Investments

148.87M

Q Short Term Debt

5.03M

Q Long Term Debt

None

Q Total Current Assets

180.32M

Q Total Current Liabilities

51.96M

Q Total Assets

263.05M

Q Total Liabilities

70.9M

Q Stockholder Equity

192.15M

AERI Charts

10-Year Chart

AERI 10-Year Chart

5-Year Chart

AERI 5-Year Chart

1-Year Chart

AERI 1-Year Chart

6-Month Chart

AERI 6-Month Chart

3-Month Chart

AERI 3-Month Chart

1-Month Chart

AERI 1-Month Chart

1-Day Chart

AERI 1-Day Chart

 

 


Research

×
Stock Streams
Global Streams

UserStreamReactionsPulseStreamSpecStreamEchoStream
Stock Streams

Message BoardSpecStream TrendingTrending StocksTV Buzz

IPO Buzz (Pricings)IPO Buzz (Upcoming)Stocks Gapping HigherTrending Public Companies (Top Volume Generators)

Uplisted StocksNew 52-Week Highs (NASDAQ)New 52-Week Highs (NYSE)New 52-Week Highs (AMEX)

Technical IndicatorsUpgradesDowngradesRecent Earnings Surprises

Market Streams

Trending IndustriesETF's by SectorSectors Top to BottomCommodities

Economic IndicatorsStock ExchangesETF Movers
Premarket Streams

NASDAQ Premarket GainersNASDAQ Premarket LosersOverseas MarketsS&P Premarket Gainers & Losers

Morning Earning ReleasesFutures

After Hours Streams

After Hours GainersAfter Hours DeclinersAfter Hours Most ActiveAfter the Bell Earning Releases
Symbol Alert Streams

Market Cap MilestonesAbove Average VolumeCurrent Movers - GainersCurrent Movers - Decliners

Short Squeeze AlertsPrice to Earnings PE AlertsPrice to Sales PS AlertsPrice to Book PB Alerts

Insider Holding AlertsInstitutional Holding AlertsLow Float StocksProfitable or Not

Cash Flow PositiveHigh Beta Volatile Stocks

Media Streams

HeadlinesMedia BuzzEconomic NewsTop Stories
Social Streams

Pulse User 'Buys'Pulse User 'Sells'B/S Today Positive Sentiment MilestonesB/S Today Negative Sentiment Milestones

Stock Follower MilestonesStocks Followed by Users


Streams
Streams
            anon
   anon